TothLovells has edged aside City rival Allen & Overy (A&O) to advise UK biotech client Celltech on its expansion into Germany’s pharmaceutical market.

A&O lost out on the deal which saw the publicly listed UK life sciences concern Celltech Group acquire German pharmaceutical company Thiemann Arzneimittel from private equity house DLJ for dm97.1m (£30.6m).